Thyas Co. Ltd. (“Thyas”; Kyoto, Japan; Representative Directors, Yasumichi Hitoshi and Ryosuke Gonotsubo) opened the Shonan Office located in the Shonan Health Innovation Park (“Shonan iPark”). In addition to its Head Office and Lab in Kyoto which focuses on translational research from universities and research institutes, Thyas plans to add its lab for process development, and in the future, clinical & commercial production of iPSC-derived therapeutic cells, at Shonan.
Ryosuke Gonotsubo, Representative Director and COO/CFO, says; “As so many excellent pharmaceutical companies, CDMOs, equipment manufacturers, system vendors, and startups open offices and labs in Shonan iPark. We are delighted to have our office in such an innovative and collaborative environment. There we expect significant collaborative opportunities with such leading companies of the industry and hope to contribute ourselves to the Shonan community.”